Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 194373, 8 pages
http://dx.doi.org/10.1155/2015/194373
Research Article

Sedum mexicanum Britt. Induces Apoptosis of Primary Rat Activated Hepatic Stellate Cells

1Department of Biological Science and Technology, College of Life Sciences, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan
2Department of Bioscience Technology, Chung Yuan Christian University, 200 Chung Pei Road, Taoyuan 32023, Taiwan
3Department of Nursing, Chang Gung University of Science and Technology, 261 Wenhwa 1st Road, Taoyuan 33303, Taiwan
4Department of Biotechnology, Asia University, 500 Lioufeng Road, Taichung 41354, Taiwan

Received 19 January 2015; Revised 28 April 2015; Accepted 4 May 2015

Academic Editor: Yibin Feng

Copyright © 2015 Shou-Lun Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Schuppan and N. H. Afdhal, “Liver cirrhosis,” The Lancet, vol. 371, no. 9615, pp. 838–851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Naveau, G. Perlemuter, and A. Balian, “Epidemiology and natural history of cirrhosis,” La Revue du Praticien, vol. 55, no. 14, pp. 1527–1532, 2005. View at Google Scholar · View at Scopus
  3. D. Ganem and A. M. Prince, “Hepatitis B virus infection-natural history and clinical consequences,” The New England Journal of Medicine, vol. 350, no. 11, pp. 1118–1129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-F. Liaw, N. Leung, J.-H. Kao et al., “Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update,” Hepatology International, vol. 2, no. 3, pp. 263–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. W.-C. Zhou, Q.-B. Zhang, and L. Qiao, “Pathogenesis of liver cirrhosis,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7312–7324, 2014. View at Publisher · View at Google Scholar
  6. T. A. Wynn and L. Barron, “Macrophages: master regulators of inflammation and fibrosis,” Seminars in Liver Disease, vol. 30, no. 3, pp. 245–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Li and S. L. Friedman, “Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy,” Journal of Gastroenterology and Hepatology, vol. 14, no. 7, pp. 618–633, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Ebrahimkhani, F. Oakley, L. B. Murphy et al., “Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease,” Nature Medicine, vol. 17, no. 12, pp. 1668–1673, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Gong, A. Pecci, S. Roth, B. Lahme, M. Beato, and A. M. Gressner, “Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand,” Hepatology, vol. 28, no. 2, pp. 492–502, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Friedman, “Mechanisms of hepatic fibrogenesis,” Gastroenterology, vol. 134, no. 6, pp. 1655–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Bataller and D. A. Brenner, “Liver fibrosis,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. L. Friedman and M. B. Bansal, “Reversal of hepatic fibrosis—fact or fantasy?” Hepatology, vol. 43, no. 2, pp. S82–S88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Feng, K.-F. Cheung, N. Wang, P. Liu, T. Nagamatsu, and Y. Tong, “Chinese medicines as a resource for liver fibrosis treatment,” Chinese Medicine, vol. 4, article 16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Y. Chor, A. Y. Hui, K. F. To et al., “Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 180–186, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. W. S. Tang and T. C. Huang, “Crassulaceae,” in Flora of Taiwan. Volume 3, T. C. Huang, Ed., p. 25, National Science Council of the Republic of China, Taipei, Taiwan, 2nd edition, 1993. View at Google Scholar
  16. D. L. Knook, A. M. Seffelaar, and A. M. de Leeuw, “Fat-storing cells of the rat liver. their isolation and purification,” Experimental Cell Research, vol. 139, no. 2, pp. 468–471, 1982. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Smedsrod and H. Pertoft, “Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence,” Journal of Leukocyte Biology, vol. 38, no. 2, pp. 213–230, 1985. View at Google Scholar · View at Scopus
  18. G. Dewson and R. M. Kluck, “Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis,” Journal of Cell Science, vol. 122, no. 16, pp. 2801–2808, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, and X. Wang, “Biochemical pathways of caspase activation during apoptosis,” Annual Review of Cell and Developmental Biology, vol. 15, pp. 269–290, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Mallat, J. Lodder, F. Teixeira-Clerc, R. Moreau, P. Codogno, and S. Lotersztajn, “Autophagy: a multifaceted partner in liver fibrosis,” BioMed Research International, vol. 2014, Article ID 869390, 7 pages, 2014. View at Publisher · View at Google Scholar
  21. C. J. Parsons, M. Takashima, and R. A. Rippe, “Molecular mechanisms of hepatic fibrogenesis,” Journal of Gastroenterology and Hepatology, vol. 22, supplement 1, pp. S79–S84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. P. Iredale, R. C. Benyon, J. Pickering et al., “Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors,” The Journal of Clinical Investigation, vol. 102, no. 3, pp. 538–549, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. A. Lazebnik, S. H. Kaufmann, S. Desnoyers, G. G. Poirier, and W. C. Earnshaw, “Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE,” Nature, vol. 371, no. 6495, pp. 346–347, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Kawada, “Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease,” Gut, vol. 55, no. 8, pp. 1073–1074, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Luk, X. Wang, P. Liu et al., “Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation,” Liver International, vol. 27, no. 7, pp. 879–890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. Y.-Z. Zhao, J.-Y. Kim, E.-J. Park et al., “Tetrandrine induces apoptosis in hepatic stellate cells,” Phytotherapy Research, vol. 18, no. 4, pp. 306–309, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Zheng and A. Chen, “Activation of PPARγ is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro,” Biochemical Journal, vol. 384, no. 1, pp. 149–157, 2004. View at Publisher · View at Google Scholar · View at Scopus